We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

GURE:NASDAQGulf Resources, Inc. Analysis

Data as of 2026-04-07 - not real-time

$6.29

Latest Price

8/10Risk

Risk Level: High

Executive Summary

The 20‑day moving average sits just above the 50‑day average, indicating a modest short‑term uptrend. The 200‑day average remains higher than the current price, suggesting longer‑term pressure. RSI hovers in the upper‑mid neutral zone, not yet overbought, while the MACD line sits above its signal, generating a bullish histogram. Volume trend is decreasing, pointing to waning trader interest, and beta is low, yet 30‑day volatility exceeds 130%, reflecting erratic price swings. The stock trades at a price‑to‑book of roughly 0.08, far below its book value per share, and a DCF model places fair value near $91, implying a massive discount to the current $6.3 price. However, the company reports negative gross and operating margins and a trailing EPS of -$49, with debt‑to‑equity exceeding 7 and free cash flow deeply negative. The basic‑materials chemicals sector is cyclical and subject to environmental regulation, adding to the risk profile. Overall, the combination of severe financial weakness and extreme valuation gap creates a high‑risk speculative profile.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 3/10

Key Factors

  • Negative earnings and high debt
  • Decreasing volume and high short‑term volatility
  • Technical bullish signals likely insufficient to offset fundamentals

Medium Term

1–3 years
Neutral
Model confidence: 4/10

Key Factors

  • Potential upside if turnaround occurs
  • Continued financial distress and cash‑flow weakness
  • Extreme valuation gap creates speculative appeal but high risk

Long Term

> 3 years
Cautious
Model confidence: 2/10

Key Factors

  • Sustained operating losses and negative free cash flow
  • Sector and regulatory headwinds for chemicals in China
  • Liquidity constraints and high drawdown history

Key Metrics & Analysis

Financial Health

Revenue Growth303.40%
Profit Margin-286.76%
ROE-43.38%
ROA-4.60%
Debt/Equity7.50
P/B Ratio0.1
Op. Cash Flow$5.5M
Free Cash Flow$-12061764

Technical Analysis

TrendNeutral
RSI58.7
Support$4.16
Resistance$8.73
MA 20$5.23
MA 50$5.08
MA 200$5.54
MACDBullish
VolumeDecreasing
Fear & Greed Index77.55

Valuation

Fair Value$91.32
GradeUndervalued
TypeValue

Risk Assessment

Beta0.40
Volatility139.29%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskMedium
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.